Market Tracker

03/22 5:16pm ET

Alere Inc (NYSE:ALR)

38.01
Delayed Data
As of 4:02pm ET
 -0.26 / -0.68%
Today’s Change
31.47
Today|||52-Week Range
51.00
-2.46%
Year-to-Date
Can Abbott Outperform Despite Alere?
9:30am / TheStreet.com - Paid Partner Content
Alere Delays Filing for 2nd Year in a Row
Mar 16 / GuruFocus News - Paid Partner Content
Stonepine Capital Management, LLC Buys Recro Pharma, SciClone Pharmaceuticals, Noveli...
Mar 21 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close38.27
Today’s open38.42
Day’s range37.95 - 38.42
Volume365,877
Average volume (3 months)631,104
Market cap$3.3B
Dividend yield--
Data as of 4:02pm ET, 03/22/2017

Growth & Valuation

Earnings growth (last year)-212.07%
Earnings growth (this year)-47.55%
Earnings growth (next 5 years)+6.70%
Revenue growth (last year)-4.77%
P/E ratioNM
Price/Sales1.36
Price/Book2.28

Competitors

 Today’s
change
Today’s
% change
NEOGNeogen Corp-1.08-1.65%
AAAPAdvanced Accelerator...+0.31+0.84%
MYGNMyriad Genetics Inc+0.28+1.48%
QDELQuidel Corp-0.17-0.79%
Data as of 3:59pm ET, 03/22/2017

Financials

Last reporting dateMarch 22, 2017
EPS forecast (this quarter)$0.52
Annual revenue (last year)$2.5B
Annual profit (last year)-$16.0M
Net profit margin-0.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Namal Nawana
Senior Vice President-
Global Operations
Mark Gladwell
Corporate headquarters
Waltham, Massachusetts

Forecasts